Novel, potent, selective, and orally bioavailable human βII-tryptase inhibitors

被引：11

作者：

Sperandio, David ^{[1
]}

Tai, Vincent W. -F. ^{[1
]}

Lohman, Julia ^{[1
]}

Hirschbein, Bernie ^{[1
]}

Mendonca, Rohan ^{[1
]}

Lee, Chang-Sun ^{[1
]}

Spencer, Jeffrey R. ^{[1
]}

Janc, James ^{[1
]}

Nguyen, Margaret ^{[1
]}

Beltman, Jerlyn ^{[1
]}

Sprengeler, Paul ^{[1
]}

Scheerens, Heleen ^{[1
]}

Lin, Tong ^{[1
]}

Liu, Liang ^{[1
]}

Gadre, Ashwini ^{[1
]}

Kellogg, Alisha ^{[1
]}

Green, Michael J. ^{[1
]}

McGrath, Mary E. ^{[1
]}

机构：

[1] Celera Gen, San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 15期

关键词：

D O I：

10.1016/j.bmcl.2006.04.088

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis of novel [1,2,4]oxadiazoles and their structure-activity relationship (SAR) for the inhibition of tryptase and related serine proteases is presented. Elaboration of the P'-side afforded potent, selective, and orally bioavailable tryptase inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：4085 / 4089

页数：5

共 50 条

[1] Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors
Hua, Zihao
Bregman, Howard
Buchanan, John L.
Chakka, Nagasree
Guzman-Perez, Angel
Gunaydin, Hakan
Huang, Xin
Gu, Yan
Berry, Virginia
Liu, Jingzhou
Teffera, Yohannes
Huang, Liyue
Egge, Bryan
Emkey, Renee
Mullady, Erin L.
Schneider, Steve
Andrews, Paul S.
Acquaviva, Lisa
Dovey, Jennifer
Mishra, Ankita
Newcomb, John
Saffran, Douglas
Serafino, Randy
Strathdee, Craig A.
Turci, Susan M.
Stanton, Mary
Wilson, Cindy
DiMauro, Erin F.
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) : 10003 - 10015
[2] Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides:: novel, potent, selective, and orally bioavailable inhibitors of βII tryptase
Levell, J
Astles, P
Eastwood, P
Cairns, J
Houille, O
Aldous, S
Merriman, G
Whiteley, B
Pribish, J
Czekaj, M
Liang, GY
Maignan, S
Guilloteau, JP
Dupuy, A
Davidson, J
Harrison, T
Morley, A
Watson, S
Fenton, G
McCarthy, C
Romano, J
Mathew, R
Engers, D
Gardyan, M
Sides, K
Kwong, J
Tsay, J
Rebello, S
Shen, LD
Wang, J
Luo, YY
Giardino, O
Lim, HK
Smith, K
Pauls, H
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (08) : 2859 - 2872
[3] Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus
Fader, Lee
Brault, Martine
Desjardins, Jessica
Dansereau, Nathalie
Lamorte, Louie
Tremblay, Sonia
Bilodeau, Francois
Bordeleau, Josee
Duplessis, Martin
Gorys, Vida
Gillard, James
Gleason, James L.
James, Clint
Joly, Marc-Andre
Kuhn, Cyrille
Llinas-Brunet, Montse
Luo, Laibin
Morency, Louis
Morin, Sebastien
Parisien, Mathieu
Poirier, Maude
Thibeault, Carl
Thao Trinh
Sturino, Claudio
Srivastava, Sanjay
Yoakim, Christiane
Franti, Michael
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (05): : 525 - 530
[4] Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
Grimster, Neil P.
Gingipalli, Lakshmaiah
Barlaam, Bernard
Su, Qibin
Zheng, XiaoLan
Watson, David
Wang, Haixia
Simpson, Iain
Pike, Andy
Balazs, Amber
Boiko, Scott
Ikeda, Timothy P.
Impastato, Anna C.
Jones, Natalie H.
Kawatkar, Sameer
Kemmitt, Paul
Lamont, Scott
Patel, Joe
Read, Jon
Sarkar, Ujjal
Sha, Li
Tomlinson, Ronald C.
Wang, Haiyun
Wilson, David M.
Zehnder, Troy E.
Wang, Lianghe
Wang, Peng
Goldberg, Frederick W.
Shao, Wenlin
Fawell, Stephen
Dry, Hannah
Dowling, James E.
Edmondson, Scott D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (19)
[5] Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2
Nguyen, Minh H.
Atasoylu, Onur
Wu, Liangxing
Kapilashrami, Kanishk
Pusey, Michelle
Gallagher, Karen
Lai, Cheng-Tsung
Zhao, Peng
Barbosa, Joseph
Liu, Kai
He, Chunhong
Zhang, Colin
Styduhar, Evan D.
Witten, Michael R.
Chen, Yaoyu
Lin, Luping
Yang, Yan-ou
Covington, Maryanne
Diamond, Sharon
Yeleswaram, Swamy
Yao, Wenqing
ACS MEDICINAL CHEMISTRY LETTERS, 2022, : 1159 - 1164
[6] Potent selective and orally bioavailable inhibition of CDK12 by novel covalent inhibitors
Poddutoori, Ramulu
Rajagopalan, Sujatha
Mukherjee, Subhendu
Marappan, Sivapriya
Samiulla, D. S.
Kasturi, Venkateswarlu
Sivakumar, Sasirekha
Nayak, Shilpa
Ravindra, M., V
Tgore, Suraj
Dhudashiya, Amit
Charamanna, K. B.
Antony, Thomas
Mahaboobi, M.
Giri, Sanjeev
Daginakatte, Girish C.
Chelur, Shekar
Ramachandra, Murali
Pandit, Chetan
Samajdar, Susanta
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
[7] From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors
Liang, Jun
Labadie, Sharada
Zhang, Birong
Ortwine, Daniel F.
Patel, Snahel
Vinogradova, Maia
Kiefer, James R.
Mauer, Till
Gehling, Victor S.
Harmange, Jean-Christophe
Cummings, Richard
Lai, Tommy
Liao, Jiangpeng
Zheng, Xiaoping
Liu, Yichin
Gustafson, Amy
Van der Porten, Erica
Mao, Weifeng
Liederer, Bianca M.
Deshmukh, Gauri
An, Le
Ran, Yingqing
Classon, Marie
Trojer, Patrick
Dragovich, Peter S.
Murray, Lesley
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (13) : 2974 - 2981
[8] Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Parthasarathy, Saravanan
Henry, Kenneth
Pei, Huaxing
Clayton, Josh
Rempala, Mark
Johns, Deidre
De Frutos, Oscar
Garcia, Pablo
Mateos, Carlos
Pleite, Sehila
Wang, Yong
Stout, Stephanie
Condon, Bradley
Ashok, Sheela
Lu, Zhohai
Ehlhardt, William
Raub, Tom
Lai, Mei
Geeganage, Sandaruwan
Burkholder, Timothy P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1887 - 1891
[9] Synthesis of potent and highly selective inhibitors of human tryptase
Slusarchyk, WA
Bolton, SA
Hartl, KS
Huang, MH
Jacobs, G
Meng, W
Ogletree, ML
Pi, ZL
Schumacher, WA
Seiler, SM
Sutton, JC
Treuner, U
Zahler, R
Zhao, GH
Bisacchi, GS
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3235 - 3238
[10] Potent and selective inhibitors of human lung tryptase.
Burgess, LE
Newhouse, BJ
Ibrahim, P
Rizzi, J
Kashem, MA
Hartman, A
Brandhuber, BJ
Wright, CD
Thomson, DS
Vigers, GPA
Koch, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U4 - U4

← 1 2 3 4 5 →